Skip to content
Home/Companies/Biotech/Noxxon

Noxxon

Biotech·France·Exited 2016·Held 9yr
Entry
2007
Hold
9yr
Exit
2016

Who owns Noxxon?

Noxxon was owned by Andera Partners through BioDiscovery 2 (2007 vintage) from 2007 to 2016, exited via Trade Sale.

Hand-verified · updated 2026-04-21

Andera Partners
Investor
Andera Partners
BioDiscovery 2 · 2007 · VC

Key facts

HQFrance
SectorBiotech
Exit Type
Trade Sale
Buyer
–
MOIC
–
Exit Year
2016

More from BioDiscovery 2

Other portfolio companies in the same fund.

SuperSonic Imagine
Exited 2019
MedTechFrance· 2008
to
Implanet
Implanet
Exited 2013
MedTechFrance· 2007
JenaValve
JenaValve
Active
MedTechFrance· 2007

More Andera Partners portfolio companies

From the same investor, across funds.

Artemys
Artemys
Exited 2025
TMTFrance
to
Inotrem
Active
BiotechFrance
Alveus Therapeutics
Alveus Therapeutics
Active
BiotechFrance· 2026
Basis
Active
· 2026
exceet Card Group
Active
TMTFrance· 2026
Rivermark Medical
Active
MedTechUS· 2026

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Noxxon

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Noxxon?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Noxxon.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue